Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer By Ogkologos - April 7, 2026 73 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the POLAR study Source RELATED ARTICLESMORE FROM AUTHOR Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC ESMO Advocates for Equal Access to Optimal Cancer Care for all Patients with Cancer at the 79th World Health Assembly Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma MOST POPULAR FDA Grants Accelerated Approval to Tarlatamab-dlle for Extensive Stage Small Cell... May 24, 2024 New hormone treatment for advanced prostate cancer made available in England June 8, 2021 Returning to Dental Care August 24, 2020 EMA Recommends Extension of Indications for Venetoclax May 14, 2021 Load more HOT NEWS How to Cope with Appetite Loss in a Loved One With... Distinct and Overlapping Pathways Contribute to the Efficacy of Nivolumab-Based Regimens... ER-Low Positive Breast Cancer Shows Similar Clinical Behaviour and Response to... As Winter Storms Plague Southern States, GreaterGood Is Helping Where It’s...
